Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists.

about

Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists.

Item

http://www.wikidata.org/entity/Q40594646

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Individualization of therapy f ...... e role of calcium antagonists.

@en

type

Item

label

Individualization of therapy f ...... e role of calcium antagonists.

@en

prefLabel

Individualization of therapy f ...... e role of calcium antagonists.

@en

P1476

Individualization of therapy f ...... e role of calcium antagonists.

@en

P2093

DeQuattro V

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

Blood pressure, stroke, and coronary heart disease

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Management of raised blood pressure in New Zealand: a discussion document.

Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. N-CAP Study Group.

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection.

Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine.

Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits.

Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging study.

P304

853-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3109/10641969409078030

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1994-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7858564

http://www.w3.org/2001/XMLSchema#string

Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists.

about

Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698